Same site recurrence following standardized high ligation and stripping of the great saphenous vein – 5‐year results of the LaVaCro trial
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2026
DOI: 10.1111/ddg.70012 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2026. Verfasst von Thomas Hummel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary vein center of the dermatological and vascular surgery clinics, Catholic Hospital of the Ruhr University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Saphenous Vein, Varicose Veins, Venous Insufficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: vein surgery working group.
Abstract (Originalsprache)
Background
Same‐site recurrence at the sapheno‐femoral junction (SFJ) takes up a large amount of the daily practice of phlebologists. Follow‐up data for high‐ligation and stripping (HL/S) of the great saphenous vein (GSV) are quite heterogenous and incoherent. This prospective multicentric study was designed to elucidate the outcome after standardized HL/S with special focus on same site groin recurrences. Patients and Methods A standardized HL/S of the GSV, including closure of the cribriform fascia, was performed. The primary endpoint was same‐site groin recurrence, assessed by clinical examination and duplex ultrasonography. Secondary endpoints were recurrences at different sites.
Results
405 patients (519 legs) from six German vein centers were included. 225 patients (287 legs, 55.56%) were available for the five‐year follow up examination. 21 legs (7.32%) suffered from clinically apparent varicosis. Same site groin recurrences were detected in five (1.74%) cases, of which only two were clinically relevant. Most clinically apparent varicose veins were caused by perforator insufficiencies.
Conclusions
The standardized technique of HL/S including ligation of small tributaries of the common femoral vein near the SFJ as well as the closure of the cribriform fascia as an anatomical barrier shows excellent results after five years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisciplinary vein center of the dermatological and vascular surgery clinics, Catholic Hospital of the Ruhr University Bochum, Bochum, Germany.
- Department of Phlebology, Artemed Fachklinik, Munich, Germany.
- Vein Center Northeim, Northeim, Germany.
- Department of vascular surgery HELIOS Klinikum Emil von Behring, Berlin, Germany.
- Department of Dermatology, University Hospital Greifswald, Greifswald, Germany.
- Vein Center Saarlouis, Saarlouis, Germany.
ORCID-Profile: Georgios Papapostolou, Dominic Mühlberger
Förderung
- vein surgery working group
Zitieren
APA
Hummel, T., Papapostolou, G., Broermann, M., Dresler, C., Flessenkämper, I., Jünger, M., Stenger, D., Mühlberger, D., Sidhwa, Y., Falkenstein, T., Stücker, M., & Mumme, A. (2026). Same site recurrence following standardized high ligation and stripping of the great saphenous vein – 5‐year results of the LaVaCro trial. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.70012
Vancouver
Hummel T, Papapostolou G, Broermann M, Dresler C, Flessenkämper I, Jünger M, et al. Same site recurrence following standardized high ligation and stripping of the great saphenous vein – 5‐year results of the LaVaCro trial. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2026. doi:10.1111/ddg.70012
BibTeX
@article{Hummel2026,
author = {Hummel, Thomas and Papapostolou, Georgios and Broermann, Margit and Dresler, Christoph and Flessenkämper, Ingo and Jünger, Michael and Stenger, Dietmar and Mühlberger, Dominic and Sidhwa, Yazad and Falkenstein, Thomas and Stücker, Markus and Mumme, Achim},
title = {Same site recurrence following standardized high ligation and stripping of the great saphenous vein – 5‐year results of the LaVaCro trial},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2026},
doi = {10.1111/ddg.70012}
}
EUVIMED